サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1408645

サルコペニア治療の市場規模・予測、世界・地域シェア、動向、成長機会分析レポート対象範囲：治療タイプ別、流通チャネル別、地域別

Sarcopenia Treatment Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment Type, Distribution Channel, and Geography
出版日: | 発行: The Insight Partners | ページ情報: 英文 134 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
サルコペニア治療の市場規模・予測、世界・地域シェア、動向、成長機会分析レポート対象範囲：治療タイプ別、流通チャネル別、地域別
出版日: 2023年12月01日
発行: The Insight Partners
ページ情報: 英文 134 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

サルコペニア治療の市場規模は、2022年の33億9,700万米ドルから2030年には52億6,400万米ドルに達すると予測されています。当レポートでは、市場の動向やサルコペニア治療市場の成長を促進・阻害する要因について取り上げています。

サルコペニアとその健康への悪影響に対する認識の高まりは、ヘルスケアと高齢者ケアの分野における進歩の大きな可能性を示しています。多くの擁護団体や組織は、大衆のサルコペニアに対する認識を高めるために積極的な対策を講じています。これらの団体はしばしば医療専門家と協力し、迅速な診断と治療の価値を強調するとともに、病原性、対象患者、予防、治療などの様々な側面について一般大衆に最新情報を提供しています。米国保健福祉省女性健康局（OWH）は2023年、女性のサルコペニアに対する認識を拡大するため、全国キャンペーン「Stronger than Sarcopenia（サルコペニアより強く）」を開始しました。米国保健福祉省の調査によると、米国の高齢者人口の45％以上がサルコペニアを患っており、数百万人の若年層が人生の後半にこの症状を発症する危険性があります。OWHの"Stronger than Sarcopenia"（サルコペニアより強く）キャンペーンに沿い、女性たちは医療提供者とサルコペニアについて話し合い、病気の検査を受け、必要であれば適切な治療を受けるよう呼びかけられています。

サルコペニアは、医学部のカリキュラムや、医師、看護師、理学療法士などのヘルスケア専門家のトレーニングプログラムにも取り入れられています。例えば、OWHはMedscape Educationと協力し、医療専門家のための継続的医学教育（CME）クレジットを作成しました。主要メディアは、記事、ニュース、ドキュメンタリーなど、サルコペニアの報道を拡大しています。2022年2月のPubMedの記事によると、米国保健福祉省は、サルコペニアに関する1,604件の研究を後援している、米国でもトップクラスの資金提供機関です。2022年からは、7月4日が「世界サルコペニア・デー」となります。このように、サルコペニアに関する意識の高まりは、今後数年間、サルコペニア治療市場に新たな成長動向をもたらす可能性が高いです。

サルコペニア治療市場は、治療タイプ別にビタミンD・カルシウムサプリメント、タンパク質サプリメント、ビタミンB12サプリメント、その他に区分されます。2022年には、ビタミンD・カルシウムサプリメント市場が最大のシェアを占めています。このセグメントのサルコペニア治療市場は、2022年から2030年にかけて最も高いCAGR 6.5％を記録すると予測されています。脂溶性ビタミンであるビタミンDは、カルシウムのホメオスタシスと健康な骨代謝の維持に不可欠です。ビタミンDの補助食品は、サルコペニアのリスクを軽減する有用な栄養戦略として研究されています。ビタミンD濃度が十分でない高齢者はサルコペニアに罹患しやすく、しばしば転倒、入院、その他の悪影響を伴う。

カナダ公衆衛生局、米国保健福祉省、NIHは、サルコペニア治療市場に関する報告書を作成する際に参照した一次情報および二次情報の一部です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 サルコペニア治療市場情勢

  • PEST分析

第5章 サルコペニア治療市場：主要産業力学

  • サルコペニア治療市場- 主要産業力学
  • 市場促進要因
    • 老人人口の増加
    • 成人における栄養不良とビタミン欠乏症の増加
  • 主な市場抑制要因
    • 直接的な治療法の入手不可能性
  • 主な市場機会
    • 臨床試験段階の製品
  • 今後の動向
    • サルコペニアに対する意識の高まり
  • 促進要因と抑制要因の影響

第6章 サルコペニア治療市場：世界市場分析

  • サルコペニア治療市場の収益、2022年～2030年
  • サルコペニア治療市場の予測と分析

第7章 サルコペニア治療市場分析：治療タイプ別

  • ビタミンDおよびカルシウムサプリメント
  • タンパク質サプリメント
  • ビタミンB12サプリメント
  • その他

第8章 サルコペニア治療市場分析：流通チャネル別

  • 薬局
  • 小売チャネル
  • オンラインチャネル
  • その他

第9章 サルコペニア治療市場：地域別分析

  • 北米
  • 欧州
  • アジア太平洋
  • 中東・アフリカ
  • 中南米

第10章 サルコペニア治療市場：業界情勢

  • サルコペニア治療市場における成長戦略
  • 無機的成長戦略
  • 有機的成長戦略

第11章 企業プロファイル

  • Abbott Laboratories
  • Bayer AG
  • Metagenics LLC
  • Nestle Health Science SA
  • Novartis AG
  • Pfizer Inc
  • Sanofi SA
  • Amway Corp
  • GSK Plc
  • Makers Nutrition LLC

第12章 付録

図表

List Of Tables

  • Table 1. Sarcopenia Treatment Market Segmentation
  • Table 2. Sarcopenia Drug Under Clinical Development
  • Table 3. Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million)
  • Table 4. Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million) - By Treatment Type
  • Table 5. Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million) - By Distribution Channel
  • Table 6. North America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 7. North America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 8. North America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Country
  • Table 9. United States Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 10. United States Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 11. Canada Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 12. Canada Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 13. Mexico Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 14. Mexico Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 15. Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 16. Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 17. Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Country
  • Table 18. Germany Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 19. Germany Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 20. France Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 21. France Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 22. United Kingdom Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 23. United Kingdom Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 24. Italy Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 25. Italy Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 26. Spain Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 27. Spain Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 28. Rest of Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 29. Rest of Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 30. Asia Pacific Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 31. Asia Pacific Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 32. Asia Pacific Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Country
  • Table 33. China Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 34. China Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 35. India Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 36. India Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 37. Japan Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 38. Japan Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 39. South Korea Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 40. South Korea Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 41. Australia Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 42. Australia Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 43. Rest of APAC Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 44. Rest of APAC Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 45. Middle East and Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 46. Middle East and Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 47. Middle East and Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Country
  • Table 48. South Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 49. South Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 50. Saudi Arabia Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 51. Saudi Arabia Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 52. United Arab Emirates Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 53. United Arab Emirates Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 54. Rest of Middle East and Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 55. Rest of Middle East and Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 56. South and Central America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 57. South and Central America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 58. South and Central America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Country
  • Table 59. Brazil Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 60. Brazil Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 61. Argentina Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 62. Argentina Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 63. Rest of South and Central America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 64. Rest of South and Central America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 65. Recent Inorganic Growth Strategies in the Sarcopenia Treatment Market
  • Table 66. Recent Organic Growth Strategies in the Sarcopenia Treatment Market
  • Table 67. Glossary of Terms, Sarcopenia Treatment Market

List Of Figures

  • Figure 1. Sarcopenia Treatment Market Segmentation, By Geography
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Sarcopenia Treatment Market Breakdown by Geography, 2022 and 2030 (%)
  • Figure 5. Sarcopenia Treatment Market Revenue (US$ Million), 2022 - 2030
  • Figure 6. Sarcopenia Treatment Market Share (%) - By Treatment Type, 2022 and 2030
  • Figure 7. Vitamin D and Calcium Supplement Market Revenue and Forecasts To 2030 (US$ Million)
  • Figure 8. Protein Supplement Market Revenue and Forecasts To 2030 (US$ Million)
  • Figure 9. Vitamin B12 Supplement Market Revenue and Forecasts To 2030 (US$ Million)
  • Figure 10. Others Market Revenue and Forecasts To 2030 (US$ Million)
  • Figure 11. Sarcopenia Treatment Market Share (%) - By Distribution Channel, 2022 and 2030
  • Figure 12. Pharmacies Market Revenue and Forecasts To 2030 (US$ Million)
  • Figure 13. Retail Channels Market Revenue and Forecasts To 2030 (US$ Million)
  • Figure 14. Online Channels Market Revenue and Forecasts To 2030 (US$ Million)
  • Figure 15. Others Market Revenue and Forecasts To 2030 (US$ Million)
  • Figure 16. Sarcopenia Treatment Market Breakdown by Region, 2022 and 2030 (%)
  • Figure 17. North America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 18. North America Sarcopenia Treatment Market Breakdown by Treatment Type (2022 and 2030)
  • Figure 19. North America Sarcopenia Treatment Market Breakdown by Distribution Channel (2022 and 2030)
  • Figure 20. North America Sarcopenia Treatment Market Breakdown by Key Countries, 2022 and 2030 (%)
  • Figure 21. United States Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 22. Canada Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 23. Mexico Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 24. Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 25. Europe Sarcopenia Treatment Market Breakdown by Treatment Type (2022 and 2030)
  • Figure 26. Europe Sarcopenia Treatment Market Breakdown by Distribution Channel (2022 and 2030)
  • Figure 27. Europe Sarcopenia Treatment Market Breakdown by Key Countries, 2022 and 2030 (%)
  • Figure 28. Germany Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 29. France Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 30. United Kingdom Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 31. Italy Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 32. Spain Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 33. Rest of Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 34. Asia Pacific Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 35. Asia Pacific Sarcopenia Treatment Market Breakdown by Treatment Type (2022 and 2030)
  • Figure 36. Asia Pacific Sarcopenia Treatment Market Breakdown by Distribution Channel (2022 and 2030)
  • Figure 37. Asia Pacific Sarcopenia Treatment Market Breakdown by Key Countries, 2022 and 2030 (%)
  • Figure 38. China Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 39. India Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 40. Japan Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 41. South Korea Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 42. Australia Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 43. Rest of APAC Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 44. Middle East and Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 45. Middle East and Africa Sarcopenia Treatment Market Breakdown by Treatment Type (2022 and 2030)
  • Figure 46. Middle East and Africa Sarcopenia Treatment Market Breakdown by Distribution Channel (2022 and 2030)
  • Figure 47. Middle East and Africa Sarcopenia Treatment Market Breakdown by Key Countries, 2022 and 2030 (%)
  • Figure 48. South Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 49. Saudi Arabia Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 50. United Arab Emirates Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 51. Rest of Middle East and Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 52. South and Central America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 53. South and Central America Sarcopenia Treatment Market Breakdown by Treatment Type (2022 and 2030)
  • Figure 54. South and Central America Sarcopenia Treatment Market Breakdown by Distribution Channel (2022 and 2030)
  • Figure 55. South and Central America Sarcopenia Treatment Market Breakdown by Key Countries, 2022 and 2030 (%)
  • Figure 56. Brazil Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 57. Argentina Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 58. Rest of South and Central America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 59. Growth Strategies in the Sarcopenia Treatment Market
目次
Product Code: TIPRE00010491

According to our latest study on "Sarcopenia Treatment Market Forecast to 2030 - Global Analysis - Treatment Type, and Distribution Channel," the sarcopenia treatment market value is expected to reach US$ 5.264 billion by 2030 from US$ 3.397 billion in 2022. The report highlights trends prevailing in the market and factors driving and hindering the growth of the sarcopenia treatment market.

The growing awareness of sarcopenia and its negative impact on health presents a significant scope for advancements in the fields of healthcare and geriatric care. Many advocacy groups and organizations are proactively taking steps to raise the awareness of sarcopenia among the masses. These organizations often work with medical professionals to keep the public updated on the various aspects of pathogenicity, target patients, prevention, and treatments, among other aspects, along with underlining the value of prompt diagnosis and treatment. The Office on Women's Health (OWH) of the US Department of Health and Human Services launched the national campaign "Stronger than Sarcopenia" in 2023 to magnify the awareness of sarcopenia in women. Research by Health and Human Services shows that more than 45% of the elderly population in the US suffers from sarcopenia, and millions of younger individuals are at risk of developing this condition later in their lives. In line with OWH's "Stronger than Sarcopenia" campaign, women are urged to discuss sarcopenia with their healthcare providers, followed by undergoing screen for the illness and taking appropriate therapy if required.

Sarcopenia has been included in the curricula of medical schools and training programs for healthcare professionals such as physicians, nurses, and physical therapists. For example, the OWH worked with Medscape Education to create continuing medical education (CME) credits for healthcare professionals, which will better equip them to detect and treat sarcopenia in their patients. Mainstream media has expanded its coverage of sarcopenia to include articles, news stories, and documentaries. According to a February 2022 PubMed article, the US Department of Health and Human Services is one of the top funding agencies in the US, sponsoring 1,604 studies on sarcopenia. From 2022, July 4 will be observed as World Sarcopenia Day. Thus, the elevating awareness regarding sarcopenia is likely to bring new growth trends into the sarcopenia treatment market in the coming years.

The sarcopenia treatment market, by treatment type, is segmented into vitamin D and calcium supplements, protein supplements, vitamin B12 supplements, and others. The vitamin D and calcium supplements segment held the largest share of the market in 2022. The sarcopenia treatment market for this segment is anticipated to record the highest CAGR of 6.5% from 2022 to 2030. Being a fat-soluble vitamin, vitamin D is crucial for maintaining calcium homeostasis and healthy bone metabolism. The supplementation of vitamin D has been studied as a useful dietary strategy to reduce the risk of sarcopenia. Older adults with suboptimal vitamin D levels are highly susceptible to sarcopenia, often associated with falls, hospitalization, and other adverse effects.

The Public Health Agency of Canada, the US Department of Health and Human Services, and NIH are a few key primary and secondary sources referred to while preparing the report on the sarcopenia treatment market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the sarcopenia treatment market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global sarcopenia treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global sarcopenia treatment market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Sarcopenia Treatment Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. Sarcopenia Treatment Market - Key Industry Dynamics

  • 5.1 Sarcopenia Treatment Market - Key Industry Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Upsurge in Geriatric Population
    • 5.2.2 Rise in Malnutrition and Vitamin Deficiency Among Adults
  • 5.3 Key Market Restraints:
    • 5.3.1 Unavailability of Direct Interventions
  • 5.4 Key Market Opportunities:
    • 5.4.1 Products in Clinical Trial Phases
  • 5.5 Future Trends:
    • 5.5.1 Rising Awareness About Sarcopenia
  • 5.6 Impact of Drivers and Restraints:

6. Sarcopenia Treatment Market - Global Market Analysis

  • 6.1 Sarcopenia Treatment Market Revenue (US$ Million), 2022 - 2030
  • 6.2 Sarcopenia Treatment Market Forecast and Analysis

7. Sarcopenia Treatment Market Analysis - By Treatment Type

  • 7.1 Vitamin D and Calcium Supplement
    • 7.1.1 Overview
    • 7.1.2 Vitamin D and Calcium Supplement Market, Revenue and Forecast to 2030 (US$ Million)
  • 7.2 Protein Supplement
    • 7.2.1 Overview
    • 7.2.2 Protein Supplement Market, Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Vitamin B12 Supplement
    • 7.3.1 Overview
    • 7.3.2 Vitamin B12 Supplement Market, Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Others
    • 7.4.1 Overview
    • 7.4.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

8. Sarcopenia Treatment Market Analysis - By Distribution Channel

  • 8.1 Pharmacies
    • 8.1.1 Overview
    • 8.1.2 Pharmacies Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.2 Retail Channels
    • 8.2.1 Overview
    • 8.2.2 Retail Channels Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.3 Online Channels
    • 8.3.1 Overview
    • 8.3.2 Online Channels Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Others
    • 8.4.1 Overview
    • 8.4.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

9. Sarcopenia Treatment Market - Geographical Analysis

  • 9.1 Overview
  • 9.2 North America
    • 9.2.1 North America Sarcopenia Treatment Market Overview
    • 9.2.2 North America Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    • 9.2.3 North America Sarcopenia Treatment Market Breakdown by Treatment Type
      • 9.2.3.1 North America Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Treatment Type
    • 9.2.4 North America Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 9.2.4.1 North America Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Distribution Channel
    • 9.2.5 North America Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
      • 9.2.5.1 North America Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
      • 9.2.5.2 United States Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.2.5.2.1 United States Sarcopenia Treatment Market Breakdown by Treatment Type
        • 9.2.5.2.2 United States Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 9.2.5.3 Canada Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.2.5.3.1 Canada Sarcopenia Treatment Market Breakdown by Treatment Type
        • 9.2.5.3.2 Canada Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 9.2.5.4 Mexico Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.2.5.4.1 Mexico Sarcopenia Treatment Market Breakdown by Treatment Type
        • 9.2.5.4.2 Mexico Sarcopenia Treatment Market Breakdown by Distribution Channel
  • 9.3 Europe
    • 9.3.1 Europe Sarcopenia Treatment Market Overview
    • 9.3.2 Europe Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    • 9.3.3 Europe Sarcopenia Treatment Market Breakdown by Treatment Type
      • 9.3.3.1 Europe Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Treatment Type
    • 9.3.4 Europe Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 9.3.4.1 Europe Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Distribution Channel
    • 9.3.5 Europe Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
      • 9.3.5.1 Europe Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
      • 9.3.5.2 Germany Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.3.5.2.1 Germany Sarcopenia Treatment Market Breakdown by Treatment Type
        • 9.3.5.2.2 Germany Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 9.3.5.3 France Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.3.5.3.1 France Sarcopenia Treatment Market Breakdown by Treatment Type
        • 9.3.5.3.2 France Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 9.3.5.4 United Kingdom Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.3.5.4.1 United Kingdom Sarcopenia Treatment Market Breakdown by Treatment Type
        • 9.3.5.4.2 United Kingdom Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 9.3.5.5 Italy Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.3.5.5.1 Italy Sarcopenia Treatment Market Breakdown by Treatment Type
        • 9.3.5.5.2 Italy Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 9.3.5.6 Spain Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.3.5.6.1 Spain Sarcopenia Treatment Market Breakdown by Treatment Type
        • 9.3.5.6.2 Spain Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 9.3.5.7 Rest of Europe Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.3.5.7.1 Rest of Europe Sarcopenia Treatment Market Breakdown by Treatment Type
        • 9.3.5.7.2 Rest of Europe Sarcopenia Treatment Market Breakdown by Distribution Channel
  • 9.4 Asia Pacific
    • 9.4.1 Asia Pacific Sarcopenia Treatment Market Overview
    • 9.4.2 Asia Pacific Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    • 9.4.3 Asia Pacific Sarcopenia Treatment Market Breakdown by Treatment Type
      • 9.4.3.1 Asia Pacific Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Treatment Type
    • 9.4.4 Asia Pacific Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 9.4.4.1 Asia Pacific Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Distribution Channel
    • 9.4.5 Asia Pacific Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
      • 9.4.5.1 Asia Pacific Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
      • 9.4.5.2 China Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.4.5.2.1 China Sarcopenia Treatment Market Breakdown by Treatment Type
        • 9.4.5.2.2 China Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 9.4.5.3 India Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.4.5.3.1 India Sarcopenia Treatment Market Breakdown by Treatment Type
        • 9.4.5.3.2 India Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 9.4.5.4 Japan Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.4.5.4.1 Japan Sarcopenia Treatment Market Breakdown by Treatment Type
        • 9.4.5.4.2 Japan Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 9.4.5.5 South Korea Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.4.5.5.1 South Korea Sarcopenia Treatment Market Breakdown by Treatment Type
        • 9.4.5.5.2 South Korea Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 9.4.5.6 Australia Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.4.5.6.1 Australia Sarcopenia Treatment Market Breakdown by Treatment Type
        • 9.4.5.6.2 Australia Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 9.4.5.7 Rest of APAC Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.4.5.7.1 Rest of APAC Sarcopenia Treatment Market Breakdown by Treatment Type
        • 9.4.5.7.2 Rest of APAC Sarcopenia Treatment Market Breakdown by Distribution Channel
  • 9.5 Middle East and Africa
    • 9.5.1 Middle East and Africa Sarcopenia Treatment Market Overview
    • 9.5.2 Middle East and Africa Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    • 9.5.3 Middle East and Africa Sarcopenia Treatment Market Breakdown by Treatment Type
      • 9.5.3.1 Middle East and Africa Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Treatment Type
    • 9.5.4 Middle East and Africa Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 9.5.4.1 Middle East and Africa Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Distribution Channel
    • 9.5.5 Middle East and Africa Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
      • 9.5.5.1 Middle East and Africa Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
      • 9.5.5.2 South Africa Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.5.5.2.1 South Africa Sarcopenia Treatment Market Breakdown by Treatment Type
        • 9.5.5.2.2 South Africa Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 9.5.5.3 Saudi Arabia Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.5.5.3.1 Saudi Arabia Sarcopenia Treatment Market Breakdown by Treatment Type
        • 9.5.5.3.2 Saudi Arabia Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 9.5.5.4 United Arab Emirates Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.5.5.4.1 United Arab Emirates Sarcopenia Treatment Market Breakdown by Treatment Type
        • 9.5.5.4.2 United Arab Emirates Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 9.5.5.5 Rest of Middle East and Africa Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.5.5.5.1 Rest of Middle East and Africa Sarcopenia Treatment Market Breakdown by Treatment Type
        • 9.5.5.5.2 Rest of Middle East and Africa Sarcopenia Treatment Market Breakdown by Distribution Channel
  • 9.6 South and Central America
    • 9.6.1 South and Central America Sarcopenia Treatment Market Overview
    • 9.6.2 South and Central America Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    • 9.6.3 South and Central America Sarcopenia Treatment Market Breakdown by Treatment Type
      • 9.6.3.1 South and Central America Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Treatment Type
    • 9.6.4 South and Central America Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 9.6.4.1 South and Central America Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Distribution Channel
    • 9.6.5 South and Central America Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
      • 9.6.5.1 South and Central America Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
      • 9.6.5.2 Brazil Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.6.5.2.1 Brazil Sarcopenia Treatment Market Breakdown by Treatment Type
        • 9.6.5.2.2 Brazil Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 9.6.5.3 Argentina Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.6.5.3.1 Argentina Sarcopenia Treatment Market Breakdown by Treatment Type
        • 9.6.5.3.2 Argentina Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 9.6.5.4 Rest of South and Central America Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.6.5.4.1 Rest of South and Central America Sarcopenia Treatment Market Breakdown by Treatment Type
        • 9.6.5.4.2 Rest of South and Central America Sarcopenia Treatment Market Breakdown by Distribution Channel

10. Sarcopenia Treatment Market-Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies in the Sarcopenia Treatment Market
  • 10.3 Inorganic Growth Strategies
    • 10.3.1 Overview
  • 10.4 Organic Growth Strategies
    • 10.4.1 Overview

11. Company Profiles

  • 11.1 Abbott Laboratories
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Bayer AG
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Metagenics LLC
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 Nestle Health Science SA
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Novartis AG
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 Pfizer Inc
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 Sanofi SA
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 Amway Corp
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Products and Services
    • 11.8.4 Financial Overview
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments
  • 11.9 GSK Plc
    • 11.9.1 Key Facts
    • 11.9.2 Business Description
    • 11.9.3 Products and Services
    • 11.9.4 Financial Overview
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Developments
  • 11.10 Makers Nutrition LLC
    • 11.10.1 Key Facts
    • 11.10.2 Business Description
    • 11.10.3 Products and Services
    • 11.10.4 Financial Overview
    • 11.10.5 SWOT Analysis
    • 11.10.6 Key Developments

12. Appendix

  • 12.1 About The Insight Partners
  • 12.2 Glossary of Terms